Vitaspring Biomedical Co. Ltd.
VSBC· OTC
VSBCVitaspring Biomedical Co. Ltd.
Filed Aug 15, 2018 · 10-Q · 15 days after period end · 0001697884-18-000013
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Revenue | $2.00K | $5.00K |
| Net Income | -$11.97K | -$1.17K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR
ended Jul 31, 2018 · filed Aug 15, 2018 · 15 d after period end
